FDA Approves LOSARTAN POTASSIUM 25 MG — Strides Pharma Science Limited

# FDA Approves Strides Pharma's Generic Losartan Potassium Tablet Strides Pharma Science Limited received FDA approval for its generic losartan potassium 25 mg tablet, expanding the competitive landscape in the angiotensin II receptor blocker market and positioning the company to capture share in the widely-prescribed hypertension treatment segment. The approval enables Strides to offer a cost-effective alternative to branded formulations, potentially benefiting patients through lower out-of-pocket costs while driving volume in the generic antihypertensive category.